These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30057165)

  • 21. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orbital atherectomy treatment of severely calcified coronary lesions in patients with impaired left ventricular ejection fraction: one-year outcomes from the ORBIT II study.
    Lee MS; Martinsen BJ; Shlofmitz R; Shlofmitz E; Lee AC; Chambers J
    EuroIntervention; 2017 Jun; 13(3):329-337. PubMed ID: 28191873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience.
    Rajdev S; Krishnan P; Irani A; Kim MC; Moreno PR; Sharma SK; Kini AS
    J Invasive Cardiol; 2008 Feb; 20(2):67-72. PubMed ID: 18252970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    Flaherty MP; Pant S; Patel SV; Kilgore T; Dassanayaka S; Loughran JH; Rawasia W; Dawn B; Cheng A; Bartoli CR
    Circ Res; 2017 Feb; 120(4):692-700. PubMed ID: 28073804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Hemodynamic Support on Outcome in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    Shamekhi J; Pütz A; Zimmer S; Tiyerili V; Mellert F; Welz A; Fimmers R; Grube E; Nickenig G; Werner N; Sinning JM
    Am J Cardiol; 2019 Jul; 124(1):20-30. PubMed ID: 31056109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous Coronary Intervention Under Cover of Left Ventricular Assist Device (Impella 2.5).
    Iftikhar I; Khan HS; Kayani AM; Shahzad H
    J Coll Physicians Surg Pak; 2015 Oct; 25 Suppl 2():S78-80. PubMed ID: 26522210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous coronary intervention in patients refused from surgery: a different entity?
    Montone RA; Niccoli G
    Minerva Cardioangiol; 2018 Oct; 66(5):562-568. PubMed ID: 29527866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary perfusion pressure and left ventricular hemodynamics as predictors of cardiovascular collapse following percutaneous coronary intervention.
    Buchanan KD; Kolm P; Iantorno M; Gajanana D; Rogers T; Gai J; Torguson R; Ben-Dor I; Suddath WO; Satler LF; Waksman R
    Cardiovasc Revasc Med; 2019 Jan; 20(1):11-15. PubMed ID: 30217626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
    Riley RF; McCabe JM; Kalra S; Lazkani M; Pershad A; Doshi D; Kirtane AJ; Nicholson W; Kearney K; Demartini T; Aaron Grantham J; Moses J; Lombardi W; Karmpaliotis D
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1261-1267. PubMed ID: 30019817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of rotational atherectomy in patients with severe left ventricular dysfunction without hemodynamic support.
    Whiteside HL; Ratanapo S; Nagabandi A; Kapoor D
    Cardiovasc Revasc Med; 2018 Sep; 19(6):660-665. PubMed ID: 29525558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.
    Aragon J; Lee MS; Kar S; Makkar RR
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):346-52. PubMed ID: 15945107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI.
    Samol A; Wiemer M; Kaese S
    Int J Cardiol; 2022 Aug; 360():7-12. PubMed ID: 35597491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions.
    Al-Rashid F; Mahabadi AA; Johannsen L; Soldat J; Dykun I; Jánosi RA; Totzeck M; Rassaf T
    Int J Cardiol Heart Vasc; 2020 Feb; 26():100445. PubMed ID: 31799370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complexity of coronary artery disease affects outcome of patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Melina G; Angeloni E; Benedetto U; Monti F; Roscitano A; Serdoz R; Sinatra R
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):656-61. PubMed ID: 22995728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prognostic Value of the Left Ventricular Ejection Fraction Is Dependent upon the Severity of Mitral Regurgitation in Patients with Acute Myocardial Infarction.
    Cho JS; Youn HJ; Her SH; Park MW; Kim CJ; Park GM; Jeong MH; Cho JY; Ahn Y; Kim KH; Park JC; Seung KB; Cho MC; Kim CJ; Kim YJ; Han KR; Kim HS;
    J Korean Med Sci; 2015 Jul; 30(7):903-10. PubMed ID: 26130953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of hypertension on postreperfusion left ventricular recovery in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.
    Vaicekavičius E; Vasiliauskas D; Navickas R; Milvidaitė I; Unikas R; Venclovienė J; Kubilius R
    Medicina (Kaunas); 2015; 51(1):38-45. PubMed ID: 25744774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender difference with the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: From pVAD Working Group.
    Doshi R; Singh A; Jauhar R; Meraj PM
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):369-378. PubMed ID: 29308660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction who underwent percutaneous coronary intervention.
    Zhong J; Chen Q; Chen L; Ye Z; Chen H; Sun J; Hong J; Ye M; Yan Y; Chen L; Luo Y
    BMC Cardiovasc Disord; 2020 Dec; 20(1):523. PubMed ID: 33317462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.